IRCT20200112046094N2 IRCT 2021-08-01 Mazandaran University of Medical Sciences Ticagrelor in minor ischemic stroke Ticagrelor plus Aspirin vs Clopidogrel plus Aspirin in MInor Non-cardioembolic Ischemic Stroke (TACAMINIS) 2021-08-07 anticipated 90 Complete https://irct.ir/trial/53887 interventional Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Other design features: this protocol designed as outcome assessor blind. The comparator group is an active group and participants treated with standard drugs, Randomization description: by using 4 block randomization method and random numbers table with 1:1 fasion. 3 Condition 1: ischemic stroke. Condition 2: transient ischemic attack. Intervention 1: Intervention group: Patients will be treat with ASA 325 mg stat and ticagrelor 180 mg stat , then ASA 80 mg daily and ticagrelor 90 mg BID for 21 days. Then ASA 80 mg daily will be continue. Intervention 2: Control group: Patients will be treat with standard minor stroke treatment, ASA 325 mg stat and clopidogrel 300 mg stat , then ASA 80 mg daily and clopidorel 75 mg daily for 21 days. Then ASA 80 mg daily will be continue. Undecided - It is not yet known if there will be a plan to make this available Justification or reason for indecision in sharing IPD is there is no further information